Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.15% | -43.61% | -33.33% | -0.59% | 178.72% |
| Total Depreciation and Amortization | -0.50% | 44.65% | 62.14% | 59.66% | 58.95% |
| Total Amortization of Deferred Charges | 55.61% | 58.48% | 56.39% | 56.67% | 56.87% |
| Total Other Non-Cash Items | 46.25% | 36.06% | 57.54% | 16.66% | -27.43% |
| Change in Net Operating Assets | 16.63% | -49.49% | -91.50% | -4.29% | 11.77% |
| Cash from Operations | 35.30% | 18.92% | 23.47% | 36.85% | 81.08% |
| Capital Expenditure | 18.37% | -276.81% | -275.79% | -56.27% | -11.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.57% | -18.59% | -48.68% | -25.22% | -32.24% |
| Cash from Investing | -43.65% | -48.26% | -79.59% | -35.01% | -21.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.89% | -99.89% | -21.08% | -- | -- |
| Repurchase of Common Stock | 97.87% | 97.21% | 75.27% | -267.47% | -659.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -423.81% | -423.81% | -207.88% | -204.81% | -- |
| Cash from Financing | 96.74% | 96.00% | 83.56% | -182.10% | -441.31% |
| Foreign Exchange rate Adjustments | -385.47% | 168.27% | -138.27% | -21.88% | 308.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.06% | 152.20% | 123.19% | -1,249.75% | -1,380.27% |